Technical Analysis for AKBA - Akebia Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 9.625 -5.17% -0.53
AKBA closed down 0.88 percent on Friday, February 21, 2020, on 1.26 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Mar 16
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical AKBA trend table...

Date Alert Name Type % Chg
New 52 Week High Strength -5.17%
Upper Bollinger Band Walk Strength -5.17%
Multiple of Ten Bullish Other -5.17%
Wide Bands Range Expansion -5.17%
Overbought Stochastic Strength -5.17%
Upper Bollinger Band Touch Strength -5.17%
New 52 Week Closing High Bullish -6.01%
Expansion Breakout Bullish Swing Setup -6.01%
Pocket Pivot Bullish Swing Setup -6.01%
New 52 Week High Strength -6.01%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Biopharmaceutical Dialysis Chronic Kidney Disease Anemia Kidney Kidney Disease Hypoxia Inducible Factors

Is AKBA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.53
52 Week Low 2.99
Average Volume 1,344,457
200-Day Moving Average 5.20
50-Day Moving Average 7.54
20-Day Moving Average 8.56
10-Day Moving Average 9.25
Average True Range 0.49
ADX 40.62
+DI 40.62
-DI 10.99
Chandelier Exit (Long, 3 ATRs ) 9.06
Chandelier Exit (Short, 3 ATRs ) 8.55
Upper Bollinger Band 10.21
Lower Bollinger Band 6.91
Percent B (%b) 0.98
BandWidth 38.56
MACD Line 0.69
MACD Signal Line 0.57
MACD Histogram 0.1226
Fundamentals Value
Market Cap 185.75 Million
Num Shares 18.3 Million
EPS -3.60
Price-to-Earnings (P/E) Ratio -2.82
Price-to-Sales 6.10
Price-to-Book 12.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.98
Resistance 3 (R3) 11.01 10.77 10.84
Resistance 2 (R2) 10.77 10.56 10.75 10.79
Resistance 1 (R1) 10.46 10.43 10.34 10.43 10.75
Pivot Point 10.22 10.22 10.16 10.20 10.22
Support 1 (S1) 9.91 10.01 9.79 9.88 9.55
Support 2 (S2) 9.67 9.88 9.65 9.51
Support 3 (S3) 9.36 9.67 9.46
Support 4 (S4) 9.33